TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive NCAB Plans Study Of Its Authorities. FDA, NIH To Provide $6.75 Million For Grants In Regulatory Science February 26, 2010
TCL Archive Scripps, Sandoz Deal Becomes Case Study As NI Rethinks Sponsored Research January 28, 1994